65
Participants
Start Date
September 24, 2021
Primary Completion Date
July 22, 2022
Study Completion Date
December 20, 2023
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda
National Institute of Allergy and Infectious Diseases (NIAID)
NIH